Oct 9th 2023- Dr. Philippe Armand- Five-year follow-up of KEYNOTE-087 By efrat|2023-09-27T07:33:50+00:00October 8th, 2023|All|Comments Off on Oct 9th 2023- Dr. Philippe Armand- Five-year follow-up of KEYNOTE-087 Share This Story, Choose Your Platform! FacebookXRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: efrat Related Posts September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy September 20th 2024- Prof. Qian Jiang- A Predictive Model for Therapy Failure in CML Patients Receiving Tyrosine Kinase Inhibitor Therapy September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis September 13th 2024- Prof. Martin Ellis- Differential Effects of Itacitinib, Fedratinib, and Ruxolitinib in Mouse Models of Hemophagocytic Lymphohistiocytosis September 2nd 2024- Prof. Mark Litzow- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults September 2nd 2024- Prof. Mark Litzow- Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults August 26th 2024- Prof. Olaf Penack- How risky is a second allogeneic stem cell transplantation? August 26th 2024- Prof. Olaf Penack- How risky is a second allogeneic stem cell transplantation? July 22nd 2024- Dr. Kai Rejeski- A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy July 22nd 2024- Dr. Kai Rejeski- A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
